Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Agile Thrpe

AGRX
Current price
2.16 USD +0.05 USD (+2.37%)
Last closed 2.11 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 5 425 186 USD
Yield for 12 month +958.82 %
Week
Month
Year
AGRX
21.11.2021 - 28.11.2021

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey. Address: 500 College Road East, Princeton, NJ, United States, 08540

Analytics

WallStreet Target Price

5 USD

P/E ratio

0.2955

Dividend Yield

Current Year

+10 884 000 USD

Last Year

+4 101 000 USD

Current Quarter

+6 662 000 USD

Last Quarter

+5 503 000 USD

Current Year

+4 048 000 USD

Last Year

-6 617 000 USD

Current Quarter

+4 185 000 USD

Last Quarter

+3 196 000 USD

Key Figures AGRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -22 333 000 USD
Operating Margin TTM -60.04 %
PE Ratio 0.2955
Return On Assets TTM -96.71 %
PEG Ratio
Return On Equity TTM -1364.04 %
Wall Street Target Price 5 USD
Revenue TTM 19 975 000 USD
Book Value -5.45 USD
Revenue Per Share TTM 12.32 USD
Dividend Share
Quarterly Revenue Growth YOY 121.9 %
Dividend Yield
Gross Profit TTM -6 617 000 USD
Earnings Share 7.31 USD
Diluted Eps TTM 7.31 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -69.72 %

Dividend Analytics AGRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AGRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 11.04.2023
Dividend Date

Stock Valuation AGRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.2955
Forward PE 2.7693
Enterprise Value Revenue 0.2538
Price Sales TTM 0.2716
Enterprise Value EBITDA -0.4223
Price Book MRQ 1.785

Financials AGRX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators AGRX

For 52 weeks

1.65 USD 16 USD
50 Day MA 1.98 USD
Shares Short Prior Month 15 945
200 Day MA 4.68 USD
Short Ratio 0.49
Shares Short 17 960
Short Percent 0.72 %